Expression of bone turnover markers in patients with tuboovarian carcinoma exposed to platinum-based chemotherapy ± bevacizumab

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Huhmann, A. [1 ]
Herz, S. [1 ]
Kurbacher, A. T. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [2 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Gynecol Oncol, Bonn, Germany
[2] Gynecol Ctr Bonn Friedenspl, Gen Gynecol & Obstet, Bonn, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0268
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [1] Direct effects of platinum-based chemotherapy ± bevacizumab on the bone metabolism of patients with primary and platinum-sensitive recurrent tuboovarian carcinoma
    Kurbacher, C. M.
    Huhmann, A.
    Herz, S.
    Monreal, K.
    Kurbacher, J. A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Alterations of bone metabolism of patients with primary and platinum-sensitive recurrent tuboovarian carcinoma induced by platinum-based chemotherapy with and without bevacizumab
    Kurbacher, C. M.
    Herz, S.
    Kurbacher, A. T.
    Rhau, W.
    Kurbacher, J. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 75 - 75
  • [3] Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
    Zhu, Yunshu
    Yang, Sheng
    Zhou, Shengyu
    Yang, Jianliang
    Qin, Yan
    Gui, Lin
    Shi, Yuankai
    He, Xiaohui
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [4] BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT
    Davidenko, I.
    Kazantseva, M.
    Porhanova, N.
    Potemin, S.
    Oganyan, M.
    Syrota, L.
    Shmatkova, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [5] Role of Fyn expression in predicting the sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Sengiku, Tomoki
    Noda, Takuya
    Awazu, Yuichiro
    Wada, Takuma
    Tasaka, Reiko
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2024, 28 (05)
  • [6] Radiation therapy to the pelvis for patients with metastatic disease treated with platinum-based chemotherapy and bevacizumab
    Wiley, R. L.
    Bondre, I. L.
    Jalloul, R.
    Klopp, A. H.
    Taylor, J. S.
    Ramondetta, L. M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 197 - 197
  • [7] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [8] FYN expression is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Noda, Takuya
    Awazu, Yuichiro
    Nanno, Shigenori
    Imai, Kenji
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A206 - A207
  • [9] PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma
    Matsubara, Hiroaki
    Fukuda, Takeshi
    Awazu, Yuichiro
    Nanno, Shigenori
    Shimomura, Masahiro
    Inoue, Yuta
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [10] Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study
    Valenza, Carmine
    Mongillo, Marta
    Boldrini, Laura
    Guidi, Lorenzo
    Farfalla, Alessia
    Malengo, Daniela
    Caruso, Giuseppe
    Lapresa, Mariateresa
    Parma, Gabriella
    Biagioli, Elena
    Curigliano, Giuseppe
    Colombo, Nicoletta
    Visconti, Maria Vittoria
    Katrini, Jalissa
    Trapani, Dario
    Derio, Silvia
    GYNECOLOGIC ONCOLOGY, 2025, 194 : 11 - 17
12345